Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Incidence, Risk Factors and Treatment of Incisional Hernia After Kidney Transplantation – An Analysis of 1564 Consecutive Patients.
L. Ooms,¹ J. Verhelst,¹ J. Jeekel,² J. IJzermans,¹ J. Lange,¹ T. Terkivatan.¹
¹Surgery, Erasmus MC, University Medical Center, Rotterdam, Netherlands; ²Neuroscience, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Purpose The objective was to evaluate the incidence and treatment of incisional hernia following kidney transplantation, and to identify potential risk factors.Methods A retrospective cohort…
2016 American Transplant Congress
Utilization of Subacute Rehabilitation Facility Early After Kidney Transplantation.
F. Luan, M. Ben-Israel, S. Mulgaonkar.
Sanit Barnabas Medical Center, Livingston, NJ.
Introduction: Although kidney transplantation is lifesaving compared to dialysis the relative risk for death is higher early after the surgery. Appropriate perioperative management could mitigate…
2016 American Transplant Congress
Hepatitis B Reactivation Among Non-Liver Solid Organ Transplant Recipients.
A. Gonzalez, F. Forouton, A. Humar, S. Husain.
Multi-Organ Transplant Program, Transplant Infectious Diseases, University Health Network, University of Toronto, Toronto, ON, Canada.
IntroductionThe purpose of this study was to evaluate the incidence of post-transplant hepatitis B (HBV) reactivation in patients who have previously cleared hepatitis B surface…
2016 American Transplant Congress
Impact of C3d and C1q-Binding DSA Detected Long-Term After Kidney Transplantation.
M. Crespo,^1,2 D. Redondo,^1,2 C. Garcia,³ J. Gimeno,⁴ M. Perez,^1,2 M. Mir,¹ J. Hernandez,³ J. Yelamos,² A. Faura,^1,2 J. Pascual.^1,2
¹Nephrology and Transplant, Hospital del Mar, Barcelona, Spain; ²Medical Research Institute (IMIM), Hospital del Mar, Barcelona, Spain; ³Catalunya Reference Laboratory, Barcelona, Spain; ⁴Pathology, Hospital del Mar, Barcelona, Spain.
HLA DSA detected after kidney transplantation(KT) correlate with outcome, but not all are equal and produce the same functional consequences. Early complement-binding DSA were asssociated…
2016 American Transplant Congress
Acquired Down-Regulation of B Cell Function Induced by Donor Blood Group Antigens After ABO-Incompatible Kidney Transplantation.
M. Tasaki,¹ K. Saito,¹ Y. Nakagawa,¹ N. Imai,² T. Aoki,³ M. Kamimura,³ K. Takahashi,¹ Y. Tomita.¹
¹Division of Urology, Department of Regenerative & Transplant Medicine, Niigata Graduate School of Medical and Dental Sciences, Niigata, Japan; ²Division of Clinical Nephrology and Rheumatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan; ³Division of Transfusion Medicine and Regenerative Medicine Bioscience Medical Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Background: The long-term of B cell immunobiology against donor blood group antigen has not been elucidated in ABO incompatible kidney transplantation (ABOi KTx).Methods: The antibody…
2016 American Transplant Congress
Post-Trial Experience with Belatacept: A Large Single Center Experience.
A. Adams, C. Garrett, J. Goldstein, R. Zhang, A. Guasch, S. Pastan, R. Patzer, A. Kirk, T. Pearson, C. Larsen.
Emory Transplant Center, Atlanta, GA.
Evaluation of belatacept in clinical trials revealed significant improvements in renal function and cardiovascular risk leading to superior survival. Despite these proven benefits higher rates…
2016 American Transplant Congress
Incidence of Post-Transplant Malignancy (PTM) After Pediatric Kidney Transplantation (PKTx).
O. Serrano,¹ A. Bangdiwala,² D. Vock,² W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas,¹ B. Chavers.³
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics, Univ. of Minnesota, Minneapolis, MN; ³Pediatrics, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: Post-transplant immunosuppression is associated with an increase in cancer rates. To date, the long-term incidence of PTM among PKTx recipients has not been well-characterized.METHODOLOGY:…
2016 American Transplant Congress
Novel Approaches to Medication Teaching in Solid Organ Transplantation.
D. Tsapepas, N. Jandovitz, S. Dulanya, D. Salerno, S. Hammad, P. Jordan.
NewYork-Presbyterian Hospital, Columbia University, New York.
Technology has become a fundamental part of our daily lives; mobile application (app) technologies enhance a healthcare providers ability to deliver patient-centered care. Solid organ…
2016 American Transplant Congress
The Clinical Differences Between First and Second Kidney Transplant in IgA Nephropathy: A Multicenter Retrospective Study.
C. Baek,¹ J. Lee,² J. Park,³ H. Kim,¹ Y. Kim,² W. Huh,³ J. Yang,⁴ D. Han,⁵ S.-K. Park.¹
¹Division of Nephrology, Asan Medical Center, Seoul, Republic of Korea; ²Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; ³Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; ⁴Transplantation Center, Seoul National University Hospital, Seoul, Republic of Korea; ⁵Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Background Recurrent IgA nephropathy (IgAN) after renal transplantation has been reported to range between 12% and 65%. However, few data are available on the second…
2016 American Transplant Congress
Prostate Cancer Characteristics and Outcome in Renal Transplant Recipients: Results from a Contemporary Monocentric Study.
C. Pettenati,¹ A.-S. Jannot,² V. Verkarre,³ S. Hurel,¹ H. Kreis,⁴ M. Housset,⁵ C. Legendre,⁴ A. Méjean,¹ M.-O. Timsit.¹
¹Department of Urology and Transplant surgery, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Descartes, Paris, France; ²Department of Statistics, Computing and Public Health, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Descartes, Paris, France; ³Department of Pathology, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France; ⁴Department of Nephrology and Transplantation, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France; ⁵Department of Onco-Radiotherapy, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France.
Objective To analyze prostate cancer characteristics in a contemporary monocentric renal transplant recipients (RTR) population and to compare oncological outcome after radical prostatectomy (RP) with…